CD4 and AIDS: The World Health Organization (WHO) [6] currently recommends initiation of ART in people living with HIV/AIDS at any CD4+ T cell count regardless of the WHO clinical stages, giving priority to those with severe or advanced HIV disease (WHO clinical stages III/IV) or a CD4 T cell count ≤350 cells/mm3.